ZA201206518B - Combination composition,comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insuficiency - Google Patents
Combination composition,comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insuficiencyInfo
- Publication number
- ZA201206518B ZA201206518B ZA2012/06518A ZA201206518A ZA201206518B ZA 201206518 B ZA201206518 B ZA 201206518B ZA 2012/06518 A ZA2012/06518 A ZA 2012/06518A ZA 201206518 A ZA201206518 A ZA 201206518A ZA 201206518 B ZA201206518 B ZA 201206518B
- Authority
- ZA
- South Africa
- Prior art keywords
- carnitine
- insuficiency
- propionyl
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10152363A EP2353596A1 (en) | 2010-02-02 | 2010-02-02 | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
US32253210P | 2010-04-09 | 2010-04-09 | |
PCT/IB2011/000200 WO2011095882A1 (en) | 2010-02-02 | 2011-02-07 | Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201206518B true ZA201206518B (en) | 2013-05-29 |
Family
ID=51844410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/06518A ZA201206518B (en) | 2010-02-02 | 2012-08-30 | Combination composition,comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insuficiency |
Country Status (7)
Country | Link |
---|---|
CA (1) | CA2787470C (en) |
CL (1) | CL2012001740A1 (en) |
HR (1) | HRP20140785T1 (en) |
MY (1) | MY182607A (en) |
PH (1) | PH12012501249A1 (en) |
SM (1) | SMT201400121B (en) |
ZA (1) | ZA201206518B (en) |
-
2011
- 2011-02-07 CA CA2787470A patent/CA2787470C/en not_active Expired - Fee Related
- 2011-02-07 HR HRP20140785AT patent/HRP20140785T1/en unknown
- 2011-02-07 MY MYPI2012002962A patent/MY182607A/en unknown
- 2011-02-07 PH PH1/2012/501249A patent/PH12012501249A1/en unknown
-
2012
- 2012-06-25 CL CL2012001740A patent/CL2012001740A1/en unknown
- 2012-08-30 ZA ZA2012/06518A patent/ZA201206518B/en unknown
-
2014
- 2014-09-01 SM SM201400121T patent/SMT201400121B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20140785T1 (en) | 2014-11-07 |
CA2787470A1 (en) | 2011-08-11 |
SMT201400121B (en) | 2014-11-10 |
CA2787470C (en) | 2018-03-27 |
PH12012501249A1 (en) | 2017-04-07 |
CL2012001740A1 (en) | 2012-11-09 |
MY182607A (en) | 2021-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2531189T3 (en) | Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency | |
EP2440209A4 (en) | Compositions and methods for the prevention and treatment of heart failure | |
IL216800A (en) | Composition for the treatment of dry eye syndrome | |
IL225471B (en) | Compositions for the prevention and treatment of cancer | |
WO2012125832A3 (en) | Antimicrobial agents | |
EP2654745A4 (en) | Composition for the treatment of skin conditions | |
SG10201501579WA (en) | Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation | |
WO2012017321A3 (en) | Treatment for dyslipidemia | |
PL2538918T3 (en) | Citicoline for the treatment of glaucoma | |
EP3037093A4 (en) | Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating chronic obstructive pulmonary diseases | |
IT1397446B1 (en) | COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND / OR TREATMENT OF RENAL DISORDERS. | |
GB0917745D0 (en) | Compositions for the prevention or treatment of migraine | |
PT2460509T (en) | Composition for the treatment of warts | |
ZA201206518B (en) | Combination composition,comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insuficiency | |
WO2014053962A3 (en) | Compositions and methods for treatment of diabetes and pre-diabetes | |
PL2686005T3 (en) | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain | |
WO2011042077A3 (en) | Transdermal therapeutic systems containing 4-n-butylresorcinol | |
WO2012013505A3 (en) | Composition comprising oxalysine | |
RS55061B1 (en) | Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome | |
HUP1100597A2 (en) | Primycin or its components or combination for the treatment or prevention of infestations by special organisms | |
HK1181051A (en) | Analogues for the treatment or prevention of flavivirus infections | |
HK1169604A (en) | Compositions and methods for the prevention and treatment of heart failure | |
EP2696879A4 (en) | Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction | |
PL1996207T3 (en) | Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome | |
HUP1100268A2 (en) | Nasale composition for the prevention of venous trombosis |